Since 2015, IBM Watson has partnered with over 60 players in the healthcare space, ranging from universities to governmental agencies.
IBM Watson Health announced two new partnerships in just the last two weeks: one on Monday with IT services company Rite Solutions to deploy Watson for cancer in Bangladeshi hospitals and one last week with Novartis to use Watson’s cognitive computing to decide on treatment combinations for breast cancer.
While Google, Apple, Amazon, and Facebook are now pushing for a foothold in the health sector, as we’ve covered in this newsletter, IBM Watson also remains one of the most visible players, frequently partnering with medical centers, biotech companies, and universities.
IBM Watson’s partnerships in healthcare have been trending up every year since 2013 according to our Company News Tab. In 2016 alone, we identified 22 Watson health partnerships including partnerships with Pfizer, Quest Diagnostics, Jefferson Health, and UC San Diego. And for 2017 year-to-date, we’ve identified at least 20 disclosed partnerships including Novartis, Illumina, Hackensack Meridian Health, Atrius Health, and the FDA, to name a few.